<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Hong_Kong_HKUST_safety"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Hong_Kong_HKUST/safety">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Hong_Kong_HKUST/safety&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/safety&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/safety&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Hong_Kong_HKUST/safety" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Hong Kong HKUST/safety</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P id="back-top" style="" display:none=""><A href="#top"><SPAN>BACK TO TOP</SPAN></A></P><DIV class="menu"><UL class="first"><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/team">Team</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/members">Members</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/advisors">Advisors</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/instructors">Instructors</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/attribution">Attribution</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/acknowledge">Acknowledgement</A></LI></UL><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project">Project</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/data">Data Page</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Wetlab">Wetlab</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/achievement">Achievement</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/medals">Medal Requirements</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/prizes">Prizes</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article/genet">Article</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</A></LI></DIV><DIV class="row"><DIV class="two columns"><UL class="side-nav"><LI><H6>Safety</H6></LI><LI><A href="#1">Biobrick Safety</A></LI><LI><A href="#2">Researcher Safety</A></LI><LI><A href="#3">Environmental Safety</A></LI><LI><A href="#4">University Safety</A></LI><LI><A href="#5">References</A></LI></UL></DIV><DIV class="ten columns team-bios-container"><DIV class="row" id="ugd-members"><DIV class="twelve columns"><H2 class="centered">Safety</H2></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Biobrick Safety</H3>
All organisms are biosafety level 1 with the minimal potential hazard to laboratory personnel and the environment. This year, our team is planning to construct a total of 7 novel basic biological parts, and to build complex devices by making use of these parts together with parts available from the Part Registry. Our BioBricks have been considered to be safe for uses and circulation. The parts and their safety evaluations are as follow.  
<H5><B><I>aceA</I> and <I>aceB</I></B></H5>
Our team is cloning isocitrate lyase (<I>aceA</I>) and malate synthase (<I>aceB</I>) from <I>E. coli</I> strain BW25113. They are enzymes involved in the glyoxylate cycle in plants and bacteria. Dean et al. at UCLA introduced <I>aceA</I> and <I>aceB</I> genes into human hepatocytes to investigate fatty acid metabolism, and no hazardous effect was reported<SUP>1</SUP>. Based on current findings, we believe the two genes will not raise any significant safety issues.
<H5><B>Mitochondrial Leader Sequence</B></H5>
Mitochondrial Leader Sequence (MLS) is a short signaling peptide that directs proteins to the mitochondria in mammalian cells. Its functionality has been tested in human hepatocytes by Bai et al. and no harmful effect of MLS has been reported<SUP>2</SUP>. Our team cloned the coding DNA sequence of MLS from a commercial plasmid – pCMV<I>/myc/mito</I> (Invitrogen) – and fused it with <I>aceA</I> and <I>aceB</I> genes so the MLS can guide the two resulting enzymes into mitochondria. Again, based on the paper written by Dean et al., and with the consideration of the signaling function of this part, we consider this BioBrick to be safe in uses.
<H5><B>Promoter of Human Elongation Factor-1 Alpha (EF-1alpha), Promoter of Peroxisome Proliferator-Activated Receptor–Alpha (PPAR-alpha), Liver Fatty Acid Binding Protein 1 (FABP1) and Glucose Regulated Protein 78 (GPR78)</B></H5>
Promoters of human elongation factor-1 alpha (EF-1alpha), peroxisome proliferator-activated receptor–alpha (PPAR-alpha), liver fatty acid binding protein 1 (FABP1) and glucose regulated protein (GRP78) are of human origins, and they govern basic metabolic reactions. Based on their functions and origin, we believe these BioBricks pose no threats to the public.
<H5><B>Bacterial Fatty Acid Metabolism Regular Protein</B></H5>
Fatty acid metabolism regular protein (<I>fadR</I>) is a bacterial transcription factor that regulates lipid metabolism of fatty acid biosynthesis and beta-oxidation. <I>fadR</I> and fatty acid dependent promoter (P<I>fadBA</I>) are obtained from the 2013 distribution kit and iGEM headquarters, submitted by the NTU-Taida 2012 team. <I>fadR</I> and P<I>fadBA</I> are native to <I>E. coli</I> and no study has been conducted in introducing them into a mammalian system. Based on the native functions of <I>fadR</I> and P<I>fadBA</I>, we believe that these two BioBricks will not raise any safety issues when introduced into a heterologous system.</DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Researcher Safety</H3>

This year, our team was authorized to work with two non-pathogenic bacterial strains, the <I>Escherichia coli</I> DH10B and SURE strains. Both strains are regularly employed in research, industry and study. Biosafety Level 1 standard regulations were strictly followed while using these strains. 

The characterization part of our project involved human liver HepG2 and HEK293FT cell lines. Only three of our trained members were allowed to enter the Tissue Culture Room and conducted experiments with HEK293FT and HepG2 cells in level 2 biosafety cabinets. They received special training about biosafety and clearly understood potential risks and methods of resolution. Gloves and lab coats were worn while researchers were in lab to avoid contamination and corrosion.

Additionally, some toxic or mutagenic substances were involved in procedures like genomic DNA extraction, cell fixation and fatty acid quantification. Phenol, chloroform, formaldehyde, BF<SUB>3</SUB>, n-heptane, diethyl ether and petroleum ether were used in the experiments mentioned above. Our team members who were dealing with these chemicals had received full supervision from lab technicians. Gloves, lab coats and protective goggles were worn during these procedures.</DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Environmental Safety</H3>

No biological system is leaked into the environment and measures are taken to limit the spread of potentially harmful genes. 
<I>E. coli</I> DH10B and SURE were used exclusively when building our constructs. The SURE Competent cells are classified to be a non-hazardous substance. All DH10B cells are classified F<SUP>-</SUP> and thus do not possess the Fertility factor. The risk of these cells acting as a donor in horizontal gene transfer via conjugation is greatly reduced. 

The <I>E. coli</I> DH10B bacterial cell strain possesses an amino acid leucine metabolism deficiency that reduces its competitiveness in the wild. Such phenotypes reduce its survival opportunities beyond the lab. 

Prior to disposal, harmful waste (toxic and/or biohazardous) was clearly separated and sterilized, either by application of bleach, or autoclaving.</DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>University Safety</H3><H5><B>Hong Kong Laws &amp; Guidelines</B></H5>
The Cartegena Protocol on Biosafety under the Convention on Biological Diversity (the Protocol) was extended to the Hong Kong Special Administrative Region (HKSAR) in May 2011. Under the Chapter 607, the Genetically Modified Organisms (Control of Release) Ordinance (the Ordinance), release of Genetically Modified Organisms (GMOs) knowingly without approval from the Deputy Director or an Assistant Director of the Agriculture, Fisheries and Conservation Department is considered an offence. The full text of Cap. 607 can be downloaded by following this <A href="http://www.legislation.gov.hk/blis_pdf.nsf/6799165D2FEE3FA94825755E0033E532/CD005BD8FCD84653482576EA0053077B/$FILE/CAP_607_e_b5.pdf">link.</A>
No part of the project is directed for release into the environment. HKUST iGEM 2013 team experiments are concerned strictly with molecular cloning and testing of recombinant technology biomolecules. Application for approval to perform such a procedure under the Ordinance is therefore not required. 

Laboratories in Hong Kong follow Guidelines on Biosafety in the Clinical Laboratory, a publication of the Centre of Health Protection under the Department of Health. The full text of the Guidelines can be accessed <A href="http://www.chp.gov.hk/files/pdf/Guidelines_on_Biosafety_in_the_Clinical_Laboratory_2nd_Edn.pdf">here</A>. As our laboratory is operated by the university’s Division of Life Science, the activities performed within the lab adhere to the above Guidelines. 

<H5><B>HKUST’s HSEO</B></H5>
The enforcement of safety regulations is handled by the university’s Health, Safety &amp; Environment Office (HSEO). The HSEO also provide safety training for staff and students for safe laboratory.

</DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>References</H3><SUP>1</SUP>Dean Jason T., et al. “Resistance to Diet-Induced Obesity in Mice with Synthetic Glyoxylate Shunt.”<SUP>2</SUP>Bai, Jingxiang, et al. &quot;Overexpression of Catalase in Cytosolic or Mitochondrial Compartment Protects HepG2 Cells against Oxidative Injury.&quot; <I>Journal of Biological Chemistry.</I> (1999): n. page. Web.</DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Hong_Kong_HKUST/safety">http://2013.igem.org/Team:Hong_Kong_HKUST/safety</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Hong_Kong_HKUST/safety" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Hong_Kong_HKUST/safety" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/safety&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/safety&amp;oldid=345571" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>